Journal of Clinical Virology
Volume 47, Issue 1 , Pages 1-3 , January 2010

Persistent adenoviraemia in an infant following haematopoietic stem cell transplantation

  • Sanjay Patel

      Affiliations

    • Department of Paediatric Immunology and Infectious Diseases, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom
  • ,
  • Mary Slatter

      Affiliations

    • Department of Paediatric Immunology and Infectious Diseases, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom
  • ,
  • Manoj Valappil

      Affiliations

    • Newcastle Health Protection Agency, Institute of Pathology, Newcastle General Hospital, United Kingdom
  • ,
  • Sheila Waugh

      Affiliations

    • Department of Microbiology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE4 6BE, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 0191 244 8948; fax: +44 0191 223 1224.

References 

  1. Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardine , Srivastava DK, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 1999;23:277–282
  2. Gavin PJ, Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics. 2002;110(1 Pt 1):e9
  3. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32(May (9)):1290–1297Epub 2001 April 10
  4. Morfin F, Dupuis-Girod S, Mundweiler S, Falcon D, Carrington D, Sedlacek P, et al. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther. 2005;10(2):225–229
  5. Morfin F, Dupuis-Girod S, Frobert E, Mundweiler S, Carrington D, Sedlacek P, et al. Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone. Antivir Ther. 2009;14(1):55–61
  6. Legrand F, Berrebi D, Houhou N, Freymuth F, Faye A, Duval M, et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 2001;27(6):621–626
  7. Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7(7):388–394
  8. Yusuf U, Hale GA, Carr J, Gu Z, Benaim E, Woodard P, et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation. 2006;81(10):1398–1404
  9. Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Characterization of human proliferative T cell responses to adenovirus. J Infect Dis. 1995;171(5):1090–1096
  10. Chatziandreou I, Gilmour KC, McNicol AM, Costabile M, Sinclair J, Cubitt D, et al. Capture and generation of adenovirus specific T cells for adoptive immunotherapy. Br J Haematol. 2007;136(January (1)):117–126Epub 2006 Nov 8

PII: S1386-6532(09)00447-8

doi: 10.1016/j.jcv.2009.09.022

Journal of Clinical Virology
Volume 47, Issue 1 , Pages 1-3 , January 2010